References
- Joint United Nations, Programme on HIV/AIDS (UNAIDS)Report on the Global AIDS EpidemicGenevaUNAIDS2008
- CadmanJArboledaCOnce or Twice: A Guide to Medication Dosing for HIV InfectionWashingtonNational Minority AIDS Council2001
- ShenLPetersonSSedaghatADose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugsNat Med20081476276618552857
- WellerIVWilliamsIGABC of AIDS: antiretroviral drugsBMJ20013221410141211397751
- ClavelFHanceAJHIV drug resistanceN Engl J Med20043501023103514999114
- CooperRDWiebeNSmithNKeiserPNaickerSTonelliMSystematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patientsClin Infect Dis20105149650520673002
- Panel on Antiretroviral Guidelines for Adults and AdolescentsGuidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and AdolescentsWashingtonDepartment of Health and Human Services2011
- CoxSWApériaKAlbertJWahrenBComparison of the sensitivities of primary isolates of HIV type 2 and HIV type 1 to antiviral drugs and drug combinationsAIDS Res Hum Retroviruses199410172517297888232
- ElionRAWittMDNucleoside and nucleotide reverse transcriptase inhibitors in the treatment of HIV: focus on efficacy2003 Available from: http://www.medscape.org/viewarticle/465383_1Accessed May 18, 2012
- NewellMA Guide to Rating Scales and QuestionnairesNew YorkOxford University Press1987
- FanningMValidation of a Quality of Life Instrument for Patients with HIV InfectionOttawaHealth and Welfare Canada1994
- Aranda-NaranjoBQuality of life in HIV-positive patientsJ Assoc Nurses AIDS Care2004152027
- FriedlandJRewickRMcCollMCoping and social support as determinants of quality of life in HIV/AIDSAIDS Care1996815318664366
- SwindellsSMohrJJustisJCBermanSSquierCWagenerMMQuality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessnessInt J STD AIDS19991038339110414881
- MarinsJRPJamalLFChenSYDramatic improvement in survival among adult Brazilian AIDS patientsAIDS2003171675168212853750
- CrumNFRiffenburghRHWegnerSComparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre, early and late HAART erasJ Acquir Immune Defic Syndr20064119420016394852
- BurgoyneRWTanDHProlongation and quality of life for HIV-infected adults treated with HAART: a balancing actJ Animicrob Chemother200861469473
- MannheimerSBMattsJTelzakEQuality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherenceAIDS2005171022
- CamposLNCésarCCGuimarãesMDCQuality of life among HIV-infected patients in Brazil after initiation of treatmentClinics (Sao Paulo)20096486787519142554
- CarrAJThompsonPWKirwanJRQuality of life measuresBr J Rheumatol1996352752818620304
- CraneHMVan RompaeySEDillinghamPWHermanEDiehrPKitahataMMA single-item measure of health-related quality of life for HIV-infected patients in routine clinical careAIDS Patient Care STDS20002016117416548713
- FleckMPALimaAFBLouzadaSAssociation of depressive symptoms and social functioning in primary care service, BrazilRev Saude Publica20023643143812364916
- CarrieriPSpireBDuranSHealth-related quality of life after 1 year of highly active antiretroviral therapyJ Acquir Immune Defic Syndr200332384712514412
- JiaHUpholdCRWuSChenGJDuncanPWPredictors of changes in health-related quality of life among men with HIV infection in the HAART eraAIDS Patient Care STDS20051939540515989435
- KemppainemJKPredictors of quality of life in AIDS patientsJ Assoc Nurses AIDS Care200112617011211673
- TostesMAChalubMBotegaNJThe quality of life of HIV-infected women is associated with psychiatric morbidityAIDS Care20041617718614676024
- ChanKSOrlandoMJoyceGCombination antiretroviral therapy and improvements in mental health: results from a nationally representative sample of persons undergoing care for HIV in the United StatesJ Acquir Immune Defic Syndr20033310411112792362
- PreauMLeportCSalmon-CeronDHealth-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatmentAIDS Care20041664966115223534
- WuAWQuality of life assessment comes of age in the era of HAARTAIDS2000141449145110930161
- GiffordALBormannJEShivelyMJWrightBCRichmanDDBozzetteSAPredictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimensJ Acquir Immune Defic Syndr20002338639510866231
- PatersonDLSwindellsSMohrJAdherence to protease inhibitor therapy and outcomes in patients with HIV infectionAnn Int Med2000133213010877736
- RaboudJMHarrisMRaeSMontanerJSImpact of adherence on duration of virological suppression among patients receiving combination antiretroviral therapyHIV Med2002311812412010358
- HoggRSYipBChanKJRates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapyJAMA20012862568257711722271
- MorganDMaheCMayanjaBOkongoJMLubegaRWhitworthJAGHIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?AIDS20021659760311873003
- MannheimerSFriedlandGMattsJChildCChesneyMThe consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trialsClin Infect Dis2002341115112111915001
- NieuwkerkPTReijersMHWeightHMLangeJMSprangiersMAQuality of life in maintenance versus prolonged induction for HIVJAMA200028417817910889587
- FumazCRTuldraAFerrerMJQuality of life, emotional status and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimensJ Acquir Defic Syndr200229244253
- Prieto-FloresMEFernández-MayoralasGRojo-PérezFEffects of sociodemographic factors on emotional and psychological status of HIV/AIDS patients on ARTRev Esp Salud Publica20088230131318711644
- LiuCJohnsonLOstrowDSilvestreAVisscherBJacobsonLPPredictors for lower quality of life in the HAART era among HIV-infected menJ Acquir Immune Defic Syndr20064247047716810114
- WoutersEHeunisCVan rensburgDMeulemansHPhysical and emotional health outcomes after 12 months of public-sector antiretroviral treatment in the Free State Province of South Africa: a longitudinal study using structural equation modellingBMC Public Health2009910319368714
- KohliRMSaneSKumarKParanjapeRSMehendaleSMModification of medical outcome study (MOS) instrument for QOL assessment and its validation in HIV infected individuals in IndiaIndian J Med Res200512229730416394320
- BadiaXPodzamczerDGarciaMLópez-LavidCCConsiglioEA randomized study comparing instruments for measuring health related quality of life in HIV-infected patientsAIDS2001131727173510509575
- GillCJGriffithJLJacobsonDSkinnerSGorbachSLWilsonIBRelationship of HIV viral loads, CD4 counts and HAART use to health related quality of lifeJ Acquir Immune Defic Syndr20023048549212154339
- CampsmithMINakashimaAKDavidsonAJSelf reported health related quality of life in persons with HIV infection:results from multisites interview projectHealth Qual Life Outcomes200311212773200
- WuAWRubinHRMathewsWCA health status questionnaire using 30 items from the medical outcomes study. Preliminary validation in persons with early HIV infectionMed Care1991297867981875745
- WareJEKosinskiMGandekBThe factor structure of SF-36 health survey in 10 countries: results from the IQOLA project. International Quality of Life AssessmentJ Clin Epidemiol199751115911659817133
- PatonNIChapmanCAChanSPValidation of the Medical Outcome Study HIV Health Survey as a measure of quality of life in HIV-infected patients in SingaporeInt J STD AIDS20021345646112171664
- SmithMYFeldmanJKellyPDeHovitzJAChirgwinKMinkoffHHealth-related quality of life of HIV-infected women: evidence for the reliability, validity and responsiveness of the Medical Outcomes Study Short-Form 20Qual Life Res1996547558901366
- WuAWRevickiDAJacobsonDMalitzFEEvidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)Qual Life Res199764814939330549
- MassadLSSpringerGJacobsonLPregnancy rates and predictors of conception, miscarriage and abortion in US women with HIVAIDS20041828128615075546
- FioreSHeardIThorneGSavasiVCollRLMiuAFertility desires and intention of HIV-positive women living in EuropeHum Reprod2001232140214418567897
- Bah’himYMOguntibejuOOLewisHAMokwenaKFactors associated with pregnancies among HIV-positive women on prevention of mother-to-child transmission programmeWest Indian Med J20105936236821355509
- MyerLCarterRJKatyalMImpact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort studyPLoS Med20107137
- KaidaAAndiaIMaierMThe potential impact of antiretroviral therapy on fertility in sub-Saharan AfricaCurr HIV/AIDS Rep2006318719417032579
- KaidaAGrayGBastosFIThe relationship between HAART use and sexual activity among HIV-positive women of reproductive age in Brazil, South Africa and UgandaAIDS Care200820212518278611
- KabueMMKekitiinwaAMagandaARisserJMChanWKlineMWGrowth in HIV-infected receiving antiretroviral therapy at a paediatric infectious diseases clinic in UgandaAIDS Patient Care STDS20082224525118298315
- MurataHHruzPWMueckerMThe mechanism of insulin resistance caused by HIV protease inhibitor therapyJ Biol Chem2000275202512025410806189
- LiangJSDisterOCooperDAHIV protease inhibitors protect apolipoprotein B from degradation by the proteosome: a potential mechanism for protease inhibitor-induced hyperlipidaemiaNat Med200171327133111726973
- BlumerRMvan VonderenMGSutinenJZidovudine-lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapyAIDS20082222723618097225
- RanadeKGeeseWJNoorMGenetic analysis implicates resistin in HIV lipodystrophyAIDS2008221561156818670214
- MarinACasadoJLAranzabalLValidation of a specific questionnaire on psychological and social repercussions of the lipodystrophy syndrome in HIV-infected patientsQual Life Res20061576777516721637
- AmmassariAMurriRPezzottiSelf-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infectionJ Acquir Immune Defic Syndr20012844544911744832
- Friis-MøllerNSabinCAWeberRCombination antiretroviral therapy and the risk of myocardial infarctionN Engl J Med20033491993200314627784
- KleinDHurleyLBQuesenberryCPJrSidneySDo protease inhibitor increase the risk for coronary heart disease in patients with HIV-1 infection?J Acquir Immune Defic Syndr20023047147712154337
- CarrAEmerySLawMAn objective case definition of lipodystrophy in HIV-infected adults: a case-control studyLancet200336172673512620736
- RiddlerSASmitEColeSRImpact of HIV infections and HAART on serum lipids in menJAMA20032892978298212799406
- NgondiJLObenJForkahDMEtameLUMbanyaDThe effect of different combination therapies on oxidative stress markers in HIV-infected patients in CameroonAIDS Res Ther200631716405737
- AllardJPAghdassiEChauJEffects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjectsAIDS199812165316599764785
- SenSKCellular thiols and redox-regulated signal transductionCurr Top Cell Regul20003613010842745
- HayesJDMcLellanLIGlutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stressFree Radic Res19993127330010517533